Trial intelligence / Profile preview

VERRUTOP for hand warts in children and adolescents

ISRCTN90862249Phase 4Completed

Sponsor
ISDIN
Start
Mar 2018
Countries
1
01

Overview

Phase 4, open-label, single-arm trial of Verrutop in Palmoplantar wart and periungual wart, sponsored by ISDIN. Primary endpoint: Complete wart clearance. Started Mar 2018; status: completed.

02

Drugs

Verrutop
03

Conditions

Palmoplantar wartperiungual wart

Beyond the preview

Go deeper on ISRCTN90862249.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN90862249.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call